These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19616430)

  • 21. Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.
    Tully DC; Liu H; Chatterjee AK; Alper PB; Epple R; Williams JA; Roberts MJ; Woodmansee DH; Masick BT; Tumanut C; Li J; Spraggon G; Hornsby M; Chang J; Tuntland T; Hollenbeck T; Gordon P; Harris JL; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5112-7. PubMed ID: 16876402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.
    Baek KH; Karki R; Lee ES; Na Y; Kwon Y
    Bioorg Chem; 2013 Dec; 51():24-30. PubMed ID: 24095934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.
    Holmes IP; Gaines S; Watson SP; Lorthioir O; Walker A; Baddeley SJ; Herbert S; Egan D; Convery MA; Singh OM; Gross JW; Strelow JM; Smith RH; Amour AJ; Brown D; Martin SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5760-3. PubMed ID: 19703773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F.
    Frizler M; Schmitz J; Schulz-Fincke AC; Gütschow M
    J Med Chem; 2012 Jun; 55(12):5982-6. PubMed ID: 22686657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors.
    Tully DC; Liu H; Chatterjee AK; Alper PB; Williams JA; Roberts MJ; Mutnick D; Woodmansee DH; Hollenbeck T; Gordon P; Chang J; Tuntland T; Tumanut C; Li J; Harris JL; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5107-11. PubMed ID: 16876407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors.
    Wiener DK; Lee-Dutra A; Bembenek S; Nguyen S; Thurmond RL; Sun S; Karlsson L; Grice CA; Jones TK; Edwards JP
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2379-82. PubMed ID: 20188543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
    Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regions.
    Wiener JJ; Wickboldt AT; Wiener DK; Lee-Dutra A; Edwards JP; Karlsson L; Nguyen S; Sun S; Jones TK; Grice CA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2375-8. PubMed ID: 20171097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B.
    Mendieta L; Picó A; Tarragó T; Teixidó M; Castillo M; Rafecas L; Moyano A; Giralt E
    ChemMedChem; 2010 Sep; 5(9):1556-67. PubMed ID: 20652927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K.
    Black WC; Bayly CI; Davis DE; Desmarais S; Falgueyret JP; Léger S; Li CS; Massé F; McKay DJ; Palmer JT; Percival MD; Robichaud J; Tsou N; Zamboni R
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4741-4. PubMed ID: 16154747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of the P2-P3 SAR of aldehyde cathepsin K inhibitors.
    Boros EE; Deaton DN; Hassell AM; McFadyen RB; Miller AB; Miller LR; Paulick MG; Shewchuk LM; Thompson JB; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3425-9. PubMed ID: 15177446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration of cathepsin S inhibitors characterized by a triazole P1-P2 amide replacement.
    Moss N; Xiong Z; Burke M; Cogan D; Gao DA; Haverty K; Heim-Riether A; Hickey ER; Nagaraja R; Netherton M; O'Shea K; Ramsden P; Schwartz R; Shih DT; Ward Y; Young E; Zhang Q
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7189-93. PubMed ID: 23084902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel fluoropeptidomimetics: synthesis, stability studies and protease inhibition.
    Annedi SC; Majumder K; Wei L; Oyiliagu CE; Samson S; Kotra LP
    Bioorg Med Chem; 2005 Apr; 13(8):2943-58. PubMed ID: 15781404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis.
    Chen JC; Uang BJ; Lyu PC; Chang JY; Liu KJ; Kuo CC; Hsieh HP; Wang HC; Cheng CS; Chang YH; Chang MD; Chang WS; Lin CC
    J Med Chem; 2010 Jun; 53(11):4545-9. PubMed ID: 20481438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From model complexes to metalloprotein inhibition: a synergistic approach to structure-based drug discovery.
    Puerta DT; Schames JR; Henchman RH; McCammon JA; Cohen SM
    Angew Chem Int Ed Engl; 2003 Aug; 42(32):3772-4. PubMed ID: 12923840
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel purine nitrile derived inhibitors of the cysteine protease cathepsin K.
    Altmann E; Cowan-Jacob SW; Missbach M
    J Med Chem; 2004 Nov; 47(24):5833-6. PubMed ID: 15537340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.
    Raghav N; Singh M
    Bioorg Chem; 2017 Dec; 75():38-49. PubMed ID: 28915464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of potent and selective MMP-13 inhibitors.
    Wu J; Rush TS; Hotchandani R; Du X; Geck M; Collins E; Xu ZB; Skotnicki J; Levin JI; Lovering FE
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4105-9. PubMed ID: 16005220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrocyclic amino carboxylates as selective MMP-8 inhibitors.
    Cherney RJ; Wang L; Meyer DT; Xue CB; Wasserman ZR; Hardman KD; Welch PK; Covington MB; Copeland RA; Arner EC; DeGrado WF; Decicco CP
    J Med Chem; 1998 May; 41(11):1749-51. PubMed ID: 9599226
    [No Abstract]   [Full Text] [Related]  

  • 40. 1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka.
    Arbuckle W; Baugh M; Belshaw S; Bennett DJ; Bruin J; Cai J; Cameron KS; Claxton C; Dempster M; Everett K; Fradera X; Hamilton W; Jones PS; Kinghorn E; Long C; Martin I; Robinson J; Westwood P
    Bioorg Med Chem Lett; 2011 Feb; 21(3):932-5. PubMed ID: 21227690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.